CYTODEL
CytoDel is a biopharmaceutical company that uses the tools of 21st-century molecular biology to produce recombinant derivatives of botulinum neurotoxin (BoNT) customized to specific applications. The technology allows CytoDel to manipulate the BoNT molecule, for next-generation BoNT products and into a drug delivery vehicle that can deliver therapeutic molecules to the inside of neurons. Biodefense is our top priority but CytoDel is developing programs to advance the treatment of nervous system disorders, chronic pain, and neurodegenerative diseases.
CYTODEL
Industry:
Biopharma Health Care Pharmaceutical Therapeutics
Founded:
2012-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.cytodel.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
225 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Content Delivery Network Font Awesome Euro Amazon Google Apps For Business
Similar Organizations
Chaperone Therapeutics
Chaperone Therapeutics is developing frontline therapies to address diseases of protein misfolding
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Palo Santo Fund
Palo Santo Fund is an investment fund that invests in psychedelic and healthcare industry.
Current Advisors List
Current Employees Featured
Founder
Investors List
Small Business Innovation Research
Small Business Innovation Research investment in Grant - Cytodel
Official Site Inspections
http://www.cytodel.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Cytodel"
About - Cytodel
CytoDel, Inc. ® 423 W 127th Street, New York, NY 10027 [email protected]See details»
Cytodel - Crunchbase Company Profile & Funding
CytoDel is a biopharmaceutical company that uses the tools of 21st-century molecular biology to produce recombinant derivatives of botulinum neurotoxin (BoNT) customized to specific …See details»
Management Team - Cytodel
Dr. Band is a co-inventor of the CytoDel technology and a co-founder of CytoDel. Dr. Band has extensive bench-to-bedside experience in biotechnology startups as former Vice President …See details»
CYTODEL Inc - LinkedIn
CYTODEL Inc | 189 followers on LinkedIn. Neuron-specific delivery of therapeutic antibodies to cytoplasm | CYTODEL Inc is a company based in New York, United States.See details»
Cytodel, Inc. Company Profile | New York, NY - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Cytodel, Inc. of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
CYTODEL Inc Overview | SignalHire Company Profile
CYTODEL Inc is a private company that has been in the industry for 13 years. The company currently specializes in the Biotechnology area. ... Organization Website. cytodel.com . Social …See details»
CytoDel Company Profile 2024: Valuation, Funding & Investors
CytoDel General Information Description. Operator of a biotechnology platform intended to produce recombinant derivatives of botulinum neurotoxin (BoNT). The company's platform …See details»
Cytodel - Funding, Financials, Valuation & Investors - Crunchbase
Cytodel offers an early biopharma with technology platform that delivers therapeutic Abs to the inside of neurons. ... Experience the new Crunchbase, powered by AI . Experience the new …See details»
Cytodel Company Profile | Management and Employees List
CytoDel's lead program is focused on developing BioBetter BoNT pharmaceuticals, offering improved safety margin and effectiveness outcomes for the treatment of large muscles and …See details»
Cytodel - Crunchbase
Cytodel offers an early biopharma with technology platform that delivers therapeutic Abs to the inside of neurons.See details»
Board of Directors - Cytodel
CytoDel, Inc. ® 423 W 127th Street, New York, NY 10027 [email protected]See details»
Cytodel - Overview, News & Similar companies | ZoomInfo.com
Jan 7, 2021 Who is Cytodel. CytoDel is a privately held biopharmaceutical company that uses the tools of 21st century molecular biology to produce recombinant derivatives of b otulinum …See details»
CytoDel - A Kairos Ventures Portfolio Company
CytoDel is a biopharmaceutical company that uses the tools of 21st century molecular biology to produce recombinant derivatives of botulinum neurotoxin (BoNT) customized to specific …See details»
CytoDel LLC - Drug pipelines, Patents, Clinical trials - Synapse
Mar 8, 2025 About CytoDel CytoDel is a privately held biopharmaceutical company that uses the tools of 21st century molecular biology to produce recombinant derivatives of botulinum …See details»
Cytodel - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Cytodel . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Member and Advisor Profiles 1. Contacts 4. About. …See details»
CytoDel Inc - BIO CEO & Investor Conference | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... CytoDel has developed a …See details»
CytoDel - Products, Competitors, Financials, Employees, …
CytoDel is a preclinical stage biopharmaceutical company focused on developing recombinant botulinum toxin derivatives for neuronal drug delivery. Use the CB Insights Platform to explore …See details»
Cytodel - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Cytodel has 1 registered patent in the ' Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering ' category, according to IPqwery. Additionally, …See details»
Programs - Cytodel
CytoDel was founded to address the limitations of the only available countermeasure to weaponized BoT, a polyclonal antitoxin that can only inactivate toxin in the circulation, BAT …See details»